Scientists in the United States and UK have determined numerous mutations to the virus which causes the illness Covid-19
However none has yet developed what this will imply for infection spread in the population and for how efficient a vaccine might be.
Viruses alter – it’s what they do.
The question is: which of these mutations actually do anything to alter the severity or infectiousness of the illness?
Preliminary research from the United States has actually suggested one specific anomaly – D614 G – is becoming dominant and could make the disease more infectious.
It hasn’t yet been evaluated by other scientists and formally released.
The scientists, from the Los Alamos National Laboratory in New Mexico, have been tracking modifications to the “spike” of the infection that gives it its unique shape, using a database called the International Effort on Sharing All Influenza Data (GISAID).
They noted there seems to be something about this particular mutation that makes it grow faster – however the effects of this are not yet clear.
The research study team analysed UK data from coronavirus patients in Sheffield. They found individuals with that particular mutation of the virus seemed to have a bigger quantity of the infection in their samples, they didn’t find evidence that those individuals became sicker or stayed in hospital for longer.
‘ Mutations not a bad thing’
Another study from University College London (UCL) determined 198 recurring anomalies to the virus.
Among its authors, Professor Francois Balloux, said: “Mutations in themselves are not a bad thing and there is nothing to recommend SARS-CoV-2 is mutating much faster or slower than anticipated.
” So far, we can not state whether SARS-CoV-2 is ending up being more or less lethal and infectious.”
A research study from the University of Glasgow, which also analysed mutations, stated these changes did not amount to various stress of the infection. They concluded that only one kind of the infection is currently distributing.
Monitoring small changes to the structure of the infection is very important in understanding the advancement of vaccines.
Take the ‘influenza infection: it alters so fast that the vaccine has to be adjusted every year to handle the particular strain in blood circulation.
Many of the Covid-19 vaccines presently in development target the unique spikes of the infection – the concept is that getting your body to recognise a distinct aspect of the spike will help it to fight off the entire infection. If that spike is altering, a vaccine established this way might become less effective.
At the minute this is all theoretical. Scientists do not yet have adequate info to say what changes to the infection’s genome will suggest.
Dr Lucy van Dorp, UCL research study co-author, stated being able to analyse a great deal of virus genomes could be “important to drug development efforts”.
However, she told the BBC: “I love genomes, however there is only so much they can state.”
Follow Rachel on Twitter